These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 16815871)
1. A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor. Yang XX; Hu ZP; Xu AL; Duan W; Zhu YZ; Huang M; Sheu FS; Zhang Q; Bian JS; Chan E; Li X; Wang JC; Zhou SF J Pharmacol Exp Ther; 2006 Oct; 319(1):82-104. PubMed ID: 16815871 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide. Yang XX; Hu ZP; Chan SY; Duan W; Ho PC; Boelsterli UA; Ng KY; Chan E; Bian JS; Chen YZ; Huang M; Zhou SF Curr Drug Metab; 2006 May; 7(4):431-55. PubMed ID: 16724931 [TBL] [Abstract][Full Text] [Related]
3. Involvement of up-regulation of hepatic breast cancer resistance protein in decreased plasma concentration of 7-ethyl-10-hydroxycamptothecin (SN-38) by coadministration of S-1 in rats. Yokoo K; Hamada A; Watanabe H; Matsuzaki T; Imai T; Fujimoto H; Masa K; Imai T; Saito H Drug Metab Dispos; 2007 Sep; 35(9):1511-7. PubMed ID: 17537871 [TBL] [Abstract][Full Text] [Related]
4. Effect of poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) micelles on pharmacokinetics and intestinal toxicity of irinotecan hydrochloride: potential involvement of breast cancer resistance protein (ABCG2). Guo S; Zhang X; Gan L; Zhu C; Gan Y J Pharm Pharmacol; 2010 Aug; 62(8):973-84. PubMed ID: 20663031 [TBL] [Abstract][Full Text] [Related]
5. Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion. Kurita A; Kado S; Kaneda N; Onoue M; Hashimoto S; Yokokura T Cancer Chemother Pharmacol; 2003 Nov; 52(5):349-60. PubMed ID: 12904895 [TBL] [Abstract][Full Text] [Related]
6. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen. Kurita A; Kado S; Matsumoto T; Asakawa N; Kaneda N; Kato I; Uchida K; Onoue M; Yokokura T Cancer Chemother Pharmacol; 2011 Jan; 67(1):201-13. PubMed ID: 20354702 [TBL] [Abstract][Full Text] [Related]
7. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. Chu XY; Kato Y; Niinuma K; Sudo KI; Hakusui H; Sugiyama Y J Pharmacol Exp Ther; 1997 Apr; 281(1):304-14. PubMed ID: 9103511 [TBL] [Abstract][Full Text] [Related]
8. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis. Hu ZP; Yang XX; Chan SY; Xu AL; Duan W; Zhu YZ; Sheu FS; Boelsterli UA; Chan E; Zhang Q; Wang JC; Ee PL; Koh HL; Huang M; Zhou SF Toxicol Appl Pharmacol; 2006 Oct; 216(2):225-37. PubMed ID: 17015070 [TBL] [Abstract][Full Text] [Related]
9. Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats. Kurita A; Kado S; Kaneda N; Onoue M; Hashimoto S; Yokokura T Cancer Chemother Pharmacol; 2000; 46(3):211-20. PubMed ID: 11021738 [TBL] [Abstract][Full Text] [Related]
11. Effect of genistein, a natural soy isoflavone, on the pharmacokinetics and intestinal toxicity of irinotecan hydrochloride in rats. Yokooji T; Kawabe Y; Mori N; Murakami T J Pharm Pharmacol; 2013 Feb; 65(2):280-91. PubMed ID: 23278696 [TBL] [Abstract][Full Text] [Related]
12. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531 [TBL] [Abstract][Full Text] [Related]
13. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2). Lalloo AK; Luo FR; Guo A; Paranjpe PV; Lee SH; Vyas V; Rubin E; Sinko PJ BMC Med; 2004 May; 2():16. PubMed ID: 15125776 [TBL] [Abstract][Full Text] [Related]
14. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Takasuna K; Hagiwara T; Hirohashi M; Kato M; Nomura M; Nagai E; Yokoi T; Kamataki T Cancer Res; 1996 Aug; 56(16):3752-7. PubMed ID: 8706020 [TBL] [Abstract][Full Text] [Related]
15. Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea. Ikegami T; Ha L; Arimori K; Latham P; Kobayashi K; Ceryak S; Matsuzaki Y; Bouscarel B Cancer Res; 2002 Jan; 62(1):179-87. PubMed ID: 11782376 [TBL] [Abstract][Full Text] [Related]
16. Novel agents that potentially inhibit irinotecan-induced diarrhea. Yang X; Hu Z; Chan SY; Chan E; Goh BC; Duan W; Zhou S Curr Med Chem; 2005; 12(11):1343-58. PubMed ID: 15975002 [TBL] [Abstract][Full Text] [Related]
17. Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset diarrhea in rats. Onoue M; Kurita A; Kado S; Matsumoto T; Kaneda N; Uchida K; Kato I; Yokokura T Cancer Chemother Pharmacol; 2008 Apr; 61(4):595-605. PubMed ID: 17549477 [TBL] [Abstract][Full Text] [Related]
18. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort. Hu ZP; Yang XX; Chen X; Cao J; Chan E; Duan W; Huang M; Yu XQ; Wen JY; Zhou SF Curr Drug Metab; 2007 Feb; 8(2):157-71. PubMed ID: 17305494 [TBL] [Abstract][Full Text] [Related]
19. Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation. Allegrini G; Di Paolo A; Cerri E; Cupini S; Amatori F; Masi G; Danesi R; Marcucci L; Bocci G; Del Tacca M; Falcone A Cancer Chemother Pharmacol; 2006 Nov; 58(5):585-93. PubMed ID: 16680463 [TBL] [Abstract][Full Text] [Related]
20. Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats. Takasuna K; Kasai Y; Kitano Y; Mori K; Kobayashi R; Hagiwara T; Kakihata K; Hirohashi M; Nomura M; Nagai E Jpn J Cancer Res; 1995 Oct; 86(10):978-84. PubMed ID: 7493918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]